Combinatorial chemistry identifies high-affinity peptidomimetics against α4β1 integrin for in vivo tumor imaging

Li Peng, Ruiwu Liu, Jan Marik, Xiaobing Wang, Yoshikazu Takada, Kit S. Lam

Research output: Contribution to journalArticle

186 Citations (Scopus)

Abstract

Small peptide-based agents have attracted wide interest as cancer-targeting agents for diagnostic imaging and targeted therapy. There is a need to develop new high-affinity and high-specificity peptidomimetic or small-molecule ligands against cancer cell surface receptors. Here we report on the identification of a high-affinity peptidomimetic ligand (LLP2A; IC50 = 2 pM) against α4β1 integrin using both diverse and highly focused one-bead-one-compound combinatorial peptidomimetic libraries in conjunction with high-stringency screening. We further demonstrate that LLP2A can be used to image α4β1-expressing lymphomas with high sensitivity and specificity when conjugated to a near infrared fluorescent dye in a mouse xenograft model. Thus, LLP2A provides an important tool for noninvasive monitoring of α4β1 expression and activity during tumor progression, and it shows great potential as an imaging and therapeutic agent for α4β1- positive tumors.

Original languageEnglish
Pages (from-to)381-389
Number of pages9
JournalNature Chemical Biology
Volume2
Issue number7
DOIs
Publication statusPublished - Jul 2006
Externally publishedYes

Fingerprint

Peptidomimetics
Integrins
Neoplasms
Ligands
Cell Surface Receptors
Diagnostic Imaging
Fluorescent Dyes
Heterografts
Inhibitory Concentration 50
Lymphoma
Sensitivity and Specificity
Peptides
Therapeutics

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

Combinatorial chemistry identifies high-affinity peptidomimetics against α4β1 integrin for in vivo tumor imaging. / Peng, Li; Liu, Ruiwu; Marik, Jan; Wang, Xiaobing; Takada, Yoshikazu; Lam, Kit S.

In: Nature Chemical Biology, Vol. 2, No. 7, 07.2006, p. 381-389.

Research output: Contribution to journalArticle

Peng, Li ; Liu, Ruiwu ; Marik, Jan ; Wang, Xiaobing ; Takada, Yoshikazu ; Lam, Kit S. / Combinatorial chemistry identifies high-affinity peptidomimetics against α4β1 integrin for in vivo tumor imaging. In: Nature Chemical Biology. 2006 ; Vol. 2, No. 7. pp. 381-389.
@article{1c2f57254b7245988e64eaf128500504,
title = "Combinatorial chemistry identifies high-affinity peptidomimetics against α4β1 integrin for in vivo tumor imaging",
abstract = "Small peptide-based agents have attracted wide interest as cancer-targeting agents for diagnostic imaging and targeted therapy. There is a need to develop new high-affinity and high-specificity peptidomimetic or small-molecule ligands against cancer cell surface receptors. Here we report on the identification of a high-affinity peptidomimetic ligand (LLP2A; IC50 = 2 pM) against α4β1 integrin using both diverse and highly focused one-bead-one-compound combinatorial peptidomimetic libraries in conjunction with high-stringency screening. We further demonstrate that LLP2A can be used to image α4β1-expressing lymphomas with high sensitivity and specificity when conjugated to a near infrared fluorescent dye in a mouse xenograft model. Thus, LLP2A provides an important tool for noninvasive monitoring of α4β1 expression and activity during tumor progression, and it shows great potential as an imaging and therapeutic agent for α4β1- positive tumors.",
author = "Li Peng and Ruiwu Liu and Jan Marik and Xiaobing Wang and Yoshikazu Takada and Lam, {Kit S.}",
year = "2006",
month = "7",
doi = "10.1038/nchembio798",
language = "English",
volume = "2",
pages = "381--389",
journal = "Nature Chemical Biology",
issn = "1552-4450",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Combinatorial chemistry identifies high-affinity peptidomimetics against α4β1 integrin for in vivo tumor imaging

AU - Peng, Li

AU - Liu, Ruiwu

AU - Marik, Jan

AU - Wang, Xiaobing

AU - Takada, Yoshikazu

AU - Lam, Kit S.

PY - 2006/7

Y1 - 2006/7

N2 - Small peptide-based agents have attracted wide interest as cancer-targeting agents for diagnostic imaging and targeted therapy. There is a need to develop new high-affinity and high-specificity peptidomimetic or small-molecule ligands against cancer cell surface receptors. Here we report on the identification of a high-affinity peptidomimetic ligand (LLP2A; IC50 = 2 pM) against α4β1 integrin using both diverse and highly focused one-bead-one-compound combinatorial peptidomimetic libraries in conjunction with high-stringency screening. We further demonstrate that LLP2A can be used to image α4β1-expressing lymphomas with high sensitivity and specificity when conjugated to a near infrared fluorescent dye in a mouse xenograft model. Thus, LLP2A provides an important tool for noninvasive monitoring of α4β1 expression and activity during tumor progression, and it shows great potential as an imaging and therapeutic agent for α4β1- positive tumors.

AB - Small peptide-based agents have attracted wide interest as cancer-targeting agents for diagnostic imaging and targeted therapy. There is a need to develop new high-affinity and high-specificity peptidomimetic or small-molecule ligands against cancer cell surface receptors. Here we report on the identification of a high-affinity peptidomimetic ligand (LLP2A; IC50 = 2 pM) against α4β1 integrin using both diverse and highly focused one-bead-one-compound combinatorial peptidomimetic libraries in conjunction with high-stringency screening. We further demonstrate that LLP2A can be used to image α4β1-expressing lymphomas with high sensitivity and specificity when conjugated to a near infrared fluorescent dye in a mouse xenograft model. Thus, LLP2A provides an important tool for noninvasive monitoring of α4β1 expression and activity during tumor progression, and it shows great potential as an imaging and therapeutic agent for α4β1- positive tumors.

UR - http://www.scopus.com/inward/record.url?scp=33745295845&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745295845&partnerID=8YFLogxK

U2 - 10.1038/nchembio798

DO - 10.1038/nchembio798

M3 - Article

C2 - 16767086

AN - SCOPUS:33745295845

VL - 2

SP - 381

EP - 389

JO - Nature Chemical Biology

JF - Nature Chemical Biology

SN - 1552-4450

IS - 7

ER -